Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen V Sigal

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|October 22, 2015
The 21st Century Cures ActMark B McClellan, Ellen V Sigal
Health Affairs (Project Hope)|June 18, 2011
Despite criticism of the FDA review process, new cancer drugs reach patients sooner in the United States than in EuropeSamantha A Roberts, Jeff D Allen, Ellen V Sigal
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2023
Novel Approach to Accelerate Lung Cancer Research: Lung-MAP and the Potential of Public-Private PartnershipsRoy S Herbst, Charles D Blanke, Ellen V Sigal
Nature Reviews. Clinical Oncology|February 6, 2020
New drug approvals in oncologyRazelle Kurzrock, Hagop M Kantarjian, Aaron S Kesselheim, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
The Value of Addressing Patient PreferencesJeff D Allen, Mark D Stewart, Samantha A Roberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Drug safety and drug efficacy: two sides of the same coinRobert C Young, Michael A Friedman, Richard L Schilsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2013
Use of multiple endpoints and approval paths depicts a decade of FDA oncology drug approvalsMichael B Shea, Samantha A Roberts, Jessica C Walrath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2011
Achieving the goals of effective, safe, and individualized cancer careSamantha A Roberts, Erin K Karnes, Jeffrey D Allen, et al.
American Health & Drug Benefits|July 24, 2020
A National Assessment of Diagnostic Test Use for Patients with Advanced NSCLC and Factors Influencing Physician Decision-MakingMadison M Wempe, Mark D Stewart, Daniel Glass, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2013
Developing standards for breakthrough therapy designation in oncologySandra J Horning, Daniel A Haber, Wendy K D Selig, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|October 22, 2015
The 21st Century Cures ActMark B McClellan, Ellen V Sigal
Health Affairs (Project Hope)|June 18, 2011
Despite criticism of the FDA review process, new cancer drugs reach patients sooner in the United States than in EuropeSamantha A Roberts, Jeff D Allen, Ellen V Sigal
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2023
Novel Approach to Accelerate Lung Cancer Research: Lung-MAP and the Potential of Public-Private PartnershipsRoy S Herbst, Charles D Blanke, Ellen V Sigal
Nature Reviews. Clinical Oncology|February 6, 2020
New drug approvals in oncologyRazelle Kurzrock, Hagop M Kantarjian, Aaron S Kesselheim, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
The Value of Addressing Patient PreferencesJeff D Allen, Mark D Stewart, Samantha A Roberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Drug safety and drug efficacy: two sides of the same coinRobert C Young, Michael A Friedman, Richard L Schilsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2013
Use of multiple endpoints and approval paths depicts a decade of FDA oncology drug approvalsMichael B Shea, Samantha A Roberts, Jessica C Walrath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2011
Achieving the goals of effective, safe, and individualized cancer careSamantha A Roberts, Erin K Karnes, Jeffrey D Allen, et al.
American Health & Drug Benefits|July 24, 2020
A National Assessment of Diagnostic Test Use for Patients with Advanced NSCLC and Factors Influencing Physician Decision-MakingMadison M Wempe, Mark D Stewart, Daniel Glass, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2013
Developing standards for breakthrough therapy designation in oncologySandra J Horning, Daniel A Haber, Wendy K D Selig, et al.
Pageof 2